CFX Add to watchlist
$40.59 +0.00 (+0.00%)
Pre-Market: $39.06 1.53 (-3.77%)
Last updated: Jul 15, 2026 09:57
52-Week Range
$39.06
$31.25 $39.06 $46.87

Fundamentals Overview

Colfax Corporation is in the middle of its 52-week range with low valuation, trending downward today.

Valuation low

P/B 1.42 P/S 0.93

Risk (Beta)

2.12 — higher vol

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 63% confidence Risk: High Volatility — Beta 2.12. Consider smaller position size due to higher beta.

Pressures (Sell):

Sentiment weakening (3 downgrades) · Beta 2.12 (elevated)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$2.12B
P/E (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
52-Week Range
$31.25 - $46.87
Volume vs Avg
N/A
Beta
2.12

About

Colfax Corporation operates as a global, diversified technology enterprise, structured into two primary divisions: Fabrication Technology and Medical Technology. The Fabrication Technology division specializes in the formulation, development, manufacturing, and supply of consumable products and associated equipment. These are crucial for industrial applications such as cutting, joining, automated welding, and gas flow control. Its comprehensive product portfolio includes a variety of welding con...
Sector: Industrials
Headquarters: US
Employees: 16,200
IPO Date: May 2008
Beta: 2.12 (More volatile than market)

Ratings & Grades at a Glance

Recent institutional grades: majority downgrades. Current institutional positions: Buy: 4, Equal Weight: 14, Hold: 1, Neutral: 3, Overweight: 5, Sell: 1, Underweight: 2.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric Value
Valuation
P/E (TTM) N/A
PEG (TTM) N/A
P/B (TTM) 1.42
P/S (TTM) 0.93
Liquidity & enterprise
Current Ratio (TTM) 2.04
Quick Ratio (TTM) 1.05
Cash Ratio (TTM) 0.05
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) -49.91%
Gross margin (TTM) 60.5%
Operating margin (TTM) -49.14%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for CFX.

Analyst Sentiment at a Glance

Sentiment Weakening
Buy 4Equal Weight 14Hold 1Neutral 3Overweight 5Sell 1Underweight 2
1 upgrade, 3 downgrades
Price Target Consensus
Current $39.06
Median $51.00
Consensus $51.00
Low consensus $45.00
High consensus $57.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Keybanc maintain Overweight Overweight 2022-03-15
Morgan Stanley maintain Equal Weight Equal Weight 2022-03-15
Stifel maintain Buy Buy 2022-02-23
Seaport Global downgrade Buy Neutral 2022-02-08
Morgan Stanley maintain Equal Weight Equal Weight 2022-01-28
Morgan Stanley maintain Equal Weight Equal Weight 2022-01-14
Loop Capital maintain Hold Hold 2022-01-06
Keybanc maintain Overweight Overweight 2021-11-05
Morgan Stanley maintain Equal Weight Equal Weight 2021-10-07
Barclays maintain Underweight Underweight 2021-10-04
Goldman Sachs downgrade Buy Neutral 2021-09-10
Morgan Stanley maintain Equal Weight Equal Weight 2021-07-30
Morgan Stanley maintain Equal Weight Equal Weight 2021-04-30
Morgan Stanley maintain Equal Weight Equal Weight 2021-04-12
Barclays downgrade Equal Weight Underweight 2021-04-06
KeyBanc maintain Overweight Overweight 2021-03-12
Morgan Stanley maintain Equal Weight Equal Weight 2021-02-22
Morgan Stanley maintain Equal Weight Equal Weight 2021-02-19
Barclays maintain Equal Weight Equal Weight 2021-02-19
Morgan Stanley maintain Equal Weight Equal Weight 2020-12-15
KeyBanc maintain Overweight Overweight 2020-11-18
UBS upgrade Neutral Buy 2020-11-09
B of A Securities maintain Buy Buy 2020-09-16
UBS maintain Neutral Neutral 2020-09-16
Morgan Stanley maintain Equal Weight Equal Weight 2020-08-07
KeyBanc maintain Overweight Overweight 2020-08-07
Barclays maintain Equal Weight Equal Weight 2020-07-07
Citigroup maintain Sell Sell 2020-05-08
Stifel maintain Buy Buy 2020-05-08
Morgan Stanley maintain Equal Weight Equal Weight 2020-05-08